Literature DB >> 16395975

How much CT do we need for PEt/CT? A radiologist's perspective.

H Kuehl1, G Antoch.   

Abstract

In clinical practice different CT imaging protocols are implemented within combined PET/CT acquisition protocols. From a radiologist's perspective the full potential of PET/ CT for oncology imaging can be used only by exploring the full capacity of the CT. This mandates the use of oral and intravenous contrast material as well as a CT image quality which proves diagnostically sufficient by radiology standards. The integration of a fully-diagnostic CT exam portion into combined PET/CT is demanding and requires adjustments of CT acquisition protocols. Given the use of the CT for CT-based attenuation correction potential PET/CT image artifacts have to be considered as well. In this paper we review radiological perspectives on PET/CT imaging.

Mesh:

Substances:

Year:  2005        PMID: 16395975

Source DB:  PubMed          Journal:  Nuklearmedizin        ISSN: 0029-5566            Impact factor:   1.379


  7 in total

1.  Multiphase contrast-enhanced CT with highly concentrated contrast agent can be used for PET attenuation correction in integrated PET/CT imaging.

Authors:  Philip Aschoff; Christian Plathow; Thomas Beyer; Matthias P Lichy; Gunter Erb; Mehmet Ö Öksüz; Claus D Claussen; Christina Pfannenberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-11-29       Impact factor: 9.236

2.  Putting 'clear' into nuclear medicine: a decade of PET/CT development.

Authors:  Thomas Beyer; David W Townsend
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-08       Impact factor: 9.236

3.  Is PET/CT necessary in paediatric oncology? For.

Authors:  Christiane Franzius; Kai Uwe Juergens; Otmar Schober
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-08       Impact factor: 9.236

Review 4.  PET/CT in paediatric oncology: indications and pitfalls.

Authors:  Christiane Franzius; Kai Uwe Juergens
Journal:  Pediatr Radiol       Date:  2009-06

5.  Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patients.

Authors:  C Riegger; J Herrmann; J Nagarajah; J Hecktor; S Kuemmel; F Otterbach; S Hahn; A Bockisch; T Lauenstein; G Antoch; T A Heusner
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-03-06       Impact factor: 9.236

6.  PET/CT in malignant melanoma: contrast-enhanced CT versus plain low-dose CT.

Authors:  Thomas Pfluger; Henriette Ingrid Melzer; Vera Schneider; Christian La Fougere; Eva Coppenrath; Carola Berking; Peter Bartenstein; Mayo Weiss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-06       Impact factor: 9.236

7.  18F-FDG PET/CT performed immediately after percutaneous ablation to evaluate outcomes of the procedure: preliminary results.

Authors:  Juliana Romanato; Marcos Roberto Menezes; Allan de Oliveira Santos; Regis Otaviano Franca Bezerra; Mariana Cunha Lopes Lima; Elba Etchebehere
Journal:  Radiol Bras       Date:  2019 Jan-Feb
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.